サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1379083

経皮ドラッグデリバリーシステム市場：世界の産業動向、シェア、市場規模、成長、機会、2023-2028年予測

Transdermal Drug Delivery Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 146 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
経皮ドラッグデリバリーシステム市場：世界の産業動向、シェア、市場規模、成長、機会、2023-2028年予測
出版日: 2023年11月02日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界の経皮ドラッグデリバリーシステムの市場規模は、2022年に63億米ドルに達しました。今後、IMARC Groupは、2022年から2028年にかけて6.5%の成長率（CAGR）を示し、2028年までに92億米ドルに達すると予測しています。

経皮ドラッグデリバリーシステム（TDDS）は、薬剤を皮膚から全身に送達する代替システムです。経口血管内、皮下、経粘膜経路の代替として使用されます。TDDSは、薬物や化粧品などの生物学的に活性な薬剤を皮膚から送達するため、慢性疾患や急性疾患、美容施術の両方をサポートします。薬剤の放出が制御されるため、初回通過代謝の影響を軽減し、副作用を軽減し、治療期間中安定した血中薬物プロファイルを可能にすることで投与効果を向上させることができます。

経皮ドラッグデリバリーシステムの市場動向：

経皮ドラッグデリバリーシステムの世界市場は、経口薬などの従来のドラッグデリバリーシステムでは治療できない慢性疾患の事例が増加していることが主な要因となっています。糖尿病などの長期的な疾患を抱える患者は、薬の自己投与にシフトしています。その結果、痛みを感じることなく毎日の投薬ができる粘着性皮膚パッチのイントロダクションが登場しました。このため、患者や医師は痛みのないドラッグデリバリーシステムを好むようになっています。これに加えて、イオントフォレーシスのような第3世代の経皮ドラッグデリバリーシステムが広く採用されるようになったことで、頻繁な通院が減り、累積治療費も少なくなるため、患者の自立が促進されるようになっています。さらに、マイクロニードルの組み込み、経皮パッチのデザインの変更、感圧接着剤や浸透促進剤の組み込みなどの技術的進歩は、メーカーに大きな機会を提供しています。

本レポートで扱う主な質問

  • 経皮ドラッグデリバリーシステムの世界市場はこれまでどのように推移してきたか？
  • COVID-19が経皮ドラッグデリバリーシステムの世界市場に与えた影響は？
  • 主要な地域市場は？
  • 技術別の市場内訳は？
  • 用途別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主な促進要因と課題は何か？
  • 経皮ドラッグデリバリーシステムの世界市場構造と主要プレイヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の経皮ドラッグデリバリーシステム市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：技術別

  • エレクトロポレーション
    • 市場動向
    • 市場予測
  • 高周波
    • 市場動向
    • 市場予測
  • イオントフォレーシス
    • 市場動向
    • 市場予測
  • マイクロポレーション
    • 市場動向
    • 市場予測
  • サーマル
    • 市場動向
    • 市場予測
  • メカニカルアレイ
    • 市場動向
    • 市場予測
  • 超音波
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 中枢神経系
    • 市場動向
    • 市場予測
  • 疼痛管理
    • 市場動向
    • 市場予測
  • 心血管
    • 市場動向
    • 市場予測
  • ホルモン
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 3M Company
    • Acrux Limited
    • Boehringer Ingelheim International GmbH
    • Hisamitsu Pharmaceutical Co. Inc.
    • Lavipharm S.A.
    • LEAD CHEMICAL Co. Ltd.
    • Luye Pharma Group
    • Nutriband Inc.
    • Viatris Inc.
図表

List of Figures

  • Figure 1: Global: Transdermal Drug Delivery Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Transdermal Drug Delivery Systems Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Transdermal Drug Delivery Systems Market: Breakup by Technology (in %), 2022
  • Figure 5: Global: Transdermal Drug Delivery Systems Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Transdermal Drug Delivery Systems Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Transdermal Drug Delivery Systems (Electroporation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Transdermal Drug Delivery Systems (Electroporation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Transdermal Drug Delivery Systems (Radiofrequency) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Transdermal Drug Delivery Systems (Radiofrequency) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Transdermal Drug Delivery Systems (Iontophoresis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Transdermal Drug Delivery Systems (Iontophoresis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Transdermal Drug Delivery Systems (Microporation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Transdermal Drug Delivery Systems (Microporation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Transdermal Drug Delivery Systems (Thermal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Transdermal Drug Delivery Systems (Thermal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Transdermal Drug Delivery Systems (Mechanical Arrays) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Transdermal Drug Delivery Systems (Mechanical Arrays) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Transdermal Drug Delivery Systems (Ultrasound) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Transdermal Drug Delivery Systems (Ultrasound) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Transdermal Drug Delivery Systems (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Transdermal Drug Delivery Systems (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Transdermal Drug Delivery Systems (Central Nervous System) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Transdermal Drug Delivery Systems (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Transdermal Drug Delivery Systems (Pain Management) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Transdermal Drug Delivery Systems (Pain Management) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Transdermal Drug Delivery Systems (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Transdermal Drug Delivery Systems (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Transdermal Drug Delivery Systems (Hormone) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Transdermal Drug Delivery Systems (Hormone) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Transdermal Drug Delivery Systems (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Transdermal Drug Delivery Systems (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: North America: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: North America: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: United States: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: United States: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Canada: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Canada: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Asia-Pacific: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Asia-Pacific: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: China: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: China: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Japan: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Japan: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: India: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: India: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: South Korea: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: South Korea: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Australia: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Australia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Indonesia: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Indonesia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Europe: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Europe: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Germany: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Germany: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: France: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: France: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: United Kingdom: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: United Kingdom: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Italy: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Italy: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Spain: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Spain: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Russia: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Russia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Latin America: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Latin America: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Brazil: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Brazil: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Mexico: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Mexico: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Middle East and Africa: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Middle East and Africa: Transdermal Drug Delivery Systems Market: Breakup by Country (in %), 2022
  • Figure 81: Middle East and Africa: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Global: Transdermal Drug Delivery Systems Industry: SWOT Analysis
  • Figure 83: Global: Transdermal Drug Delivery Systems Industry: Value Chain Analysis
  • Figure 84: Global: Transdermal Drug Delivery Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transdermal Drug Delivery Systems Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 3: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Transdermal Drug Delivery Systems Market: Competitive Structure
  • Table 6: Global: Transdermal Drug Delivery Systems Market: Key Players
目次
Product Code: SR112023A3983

Abstract

The global transdermal drug delivery systems market size reached US$ 6.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.2 Billion by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2022-2028.

The transdermal drug delivery system (TDDS) is an alternative system of delivering drugs through the skin for systemic distribution. It is used as an alternative to oral intravascular, subcutaneous, and transmucosal routes. TDDS supports both chronic and acute diseases as well as cosmetic procedures as it delivers biologically active agents, such as drugs and cosmeceuticals, through the skin. It offers a controlled release of drugs, which reduces the first-pass metabolism effects, lessens the side effects, and improves the efficacy of the dosage by enabling a steady blood drug profile throughout the treatment.

Transdermal Drug Delivery System Market Trends:

The global transdermal drug delivery systems market is primarily driven by the growing instances of chronic disorders that cannot be treated through conventional drug delivery systems, such as oral drugs. Patients with long-term ailments, such as diabetes, are shifting toward self-administration of medicine. As a result, there has been an introduction of adhesive skin patches to administer the daily course of medication without the pain. This has encouraged patients and physicians to prefer pain-free drug delivery systems. Besides this, the wide adoption of third-generation transdermal drug delivery systems like iontophoresis promotes self-reliance in patients since it reduces frequent visits to hospitals and lessens the cumulative treatment costs. Furthermore, technological advancements, such as the inclusion of microneedles, modifications in transdermal patch designs and the incorporation of pressure-sensitive adhesives and permeation enhancers, are providing vast opportunities to manufacturers.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global transdermal drug delivery systems market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on technology and application.

Breakup by Technology:

Electroporation

Radiofrequency

Iontophoresis

Microporation

Thermal

Mechanical Arrays

Ultrasound

Others

Breakup by Application:

Central Nervous System

Pain Management

Cardiovascular

Hormone

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Acrux Limited, Boehringer Ingelheim International GmbH, Hisamitsu Pharmaceutical Co. Inc., Lavipharm S.A., LEAD CHEMICAL Co. Ltd., Luye Pharma Group, Nutriband Inc. and Viatris Inc.

Key Questions Answered in This Report:

  • How has the global transdermal drug delivery systems market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global transdermal drug delivery systems market?
  • What are the key regional markets?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global transdermal drug delivery systems market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transdermal Drug Delivery Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Electroporation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Radiofrequency
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Iontophoresis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Microporation
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Thermal
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Mechanical Arrays
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Ultrasound
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Central Nervous System
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pain Management
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiovascular
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Hormone
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Acrux Limited
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Boehringer Ingelheim International GmbH
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Hisamitsu Pharmaceutical Co. Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Lavipharm S.A.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 LEAD CHEMICAL Co. Ltd.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Luye Pharma Group
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
    • 13.3.8 Nutriband Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Viatris Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials